|

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

RECRUITINGN/ASponsored by Oregon Health and Science University
Actively Recruiting
PhaseN/A
SponsorOregon Health and Science University
Started2025-01-22
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06409169

Summary

The purpose of this study is to compare the rate of treatment initiation achieved by peer-assisted telemedicine contingent on phlebotomy (usual care) versus that achieved with a new protocol, called Dried Blood Spot Test and Treat (DBS TaT). DBS TaT includes DBS testing to diagnose hepatitis C (HCV), utilizes a novel clinical decision aid that identifies patients who are low risk for hepatic (liver) fibrosis, and directs those patients to HCV treatment initiation prior to routine hepatic fibrosis assessment. The investigators hypothesize that DBS TaT will increase the rate of HCV treatment initiation compared to peer-assisted telemedicine contingent on phlebotomy (usual care).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Active hepatitis C infection
* Willing to engaged with the PATHS program for clinical care

Exclusion Criteria:

• Currently pregnant

Conditions2

Hepatitis CLiver Disease

Locations1 site

Oregon Health & Science University
Portland, Oregon, 97239
Tonhi Gailey503 494 8311gailey@ohsu.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.